Our story:
FDA approves new pancreatic cancer drug expected to usher in new era of treatment
The therapy, Rasonque from Revolution Medicines $RVMD, nearly doubled overall survival in a key clinical trial
Show more
Register and share your invite link to earn from video plays and referrals.
